Ultramicrosize Griseofulvin Tablet
Product Images NDC 42794-013

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ultramicrosize Griseofulvin (NDC 42794-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sigmapharm Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

125 mg Container Label-30 Fill (Mm2)

Ultramicrosize Griseofulvin Tablets, USP 125 mg oral tablets packaging label from SigmaPharm Laboratories, LLC. The label indicates each tablet contains 125 mg of ultramicrosize crystals of griseofulvin, with a package size of 30 tablets. Storage and handling instructions are included, along with the NDC 42794-013-08 and barcode.*

FDA Label Image

Image Description (Mm3)

Ultramicrosize Griseofulvin Tablets USP 250 mg oral tablets, packaged in a container of 30 tablets. The label shows the active ingredient as ultramicrosize crystals of griseofulvin 250 mg per tablet. It is manufactured by Sigmapharm Laboratories, LLC. The label includes storage instructions and a barcode with NDC 42794-014-08.*

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredient Ultramicrosize Griseofulvin, showing the arrangement of functional groups and bonds in the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.